Nifty

:

22402.40

Sensex

:

73852.94

34.40 (0.15%)
114.49 (0.16%)

Login

Nifty
Sensex

:
:

22402.40
73852.94

34.40 (0.15%)
114.49 (0.16%)

Anuh Pharma Ltd.

Pharmaceuticals & Drugs - API

Rating :

75/99

BSE: 506260 | NSE: Not Listed

Watchlist

NSE BSE

236.05

24-Apr-2024

Open
High
Low
Previous Close

237.30
243.70
232.55
236.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

476
83.41
265.00
86.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,185.90
21.83
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,178.82
0.85%
4.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.07
10.47
6.89

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.87
11.58
2.80

PAT CAGR (%)

10 Years
5 Years
3 Years

7.48
9.13
8.35

P:E (Median)

8 Years
5 Years
3 Years

20.53
17.96
16.82

P:BV (Average)

8 Years
5 Years
3 Years

2.86
2.86
2.65

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.86
11.77
10.96

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 172.10 138.73 24.05% 149.53 115.07 29.95% 161.48 116.38 38.75% 157.31 128.97 21.97%
Expenses 148.11 126.30 17.27% 131.57 101.64 29.45% 147.50 105.19 40.22% 143.08 115.10 24.31%
EBITDA 23.99 12.43 93.00% 17.96 13.43 33.73% 13.98 11.18 25.04% 14.23 13.87 2.60%
EBIDTM 13.94% 8.96% 12.01% 11.67% 8.65% 9.61% 9.05% 10.75%
Other Income 3.66 2.11 73.46% 2.15 2.01 6.97% 3.47 0.96 261.46% 1.04 1.03 0.97%
Interest 0.14 0.03 366.67% 0.09 0.11 -18.18% 0.02 0.06 -66.67% 0.02 -0.18 -
Depreciation 2.20 2.43 -9.47% 2.15 2.44 -11.89% 2.01 2.42 -16.94% 2.41 3.01 -19.93%
PBT 25.30 12.08 109.44% 17.88 12.89 38.71% 15.41 9.66 59.52% 12.84 12.07 6.38%
Tax 6.19 2.77 123.47% 4.04 2.97 36.03% 3.66 2.33 57.08% 3.22 3.14 2.55%
PAT 19.11 9.31 105.26% 13.83 9.92 39.42% 11.75 7.33 60.30% 9.62 8.93 7.73%
PATM 11.11% 6.71% 9.25% 8.62% 7.28% 6.30% 6.12% 6.92%
EPS 3.81 1.86 104.84% 2.76 1.98 39.39% 2.35 1.46 60.96% 1.92 1.78 7.87%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 640.42 527.49 486.65 431.96 306.96 320.66 238.09 206.15 326.22 283.69 266.40 Net Sales Growth 28.30% 8.39% 12.66% 40.72% -4.27% 34.68% 15.49% -36.81% 14.99% 6.49% Cost Of Goods Sold 488.06 399.11 375.48 327.60 228.64 241.48 179.59 149.43 247.00 220.09 213.02 Gross Profit 152.36 128.38 111.16 104.36 78.32 79.19 58.50 56.72 79.23 63.60 53.37 GP Margin 23.79% 24.34% 22.84% 24.16% 25.51% 24.70% 24.57% 27.51% 24.29% 22.42% 20.03% Total Expenditure 570.26 475.68 439.18 386.84 283.73 290.70 219.77 183.46 288.67 252.66 242.11 Power & Fuel Cost - 11.02 8.80 8.66 6.31 4.79 4.09 3.07 3.48 3.22 2.85 % Of Sales - 2.09% 1.81% 2.00% 2.06% 1.49% 1.72% 1.49% 1.07% 1.14% 1.07% Employee Cost - 17.15 15.10 14.29 13.36 10.14 8.90 7.22 6.58 5.62 4.67 % Of Sales - 3.25% 3.10% 3.31% 4.35% 3.16% 3.74% 3.50% 2.02% 1.98% 1.75% Manufacturing Exp. - 23.90 18.30 16.76 14.44 15.03 11.82 12.93 14.54 11.28 8.44 % Of Sales - 4.53% 3.76% 3.88% 4.70% 4.69% 4.96% 6.27% 4.46% 3.98% 3.17% General & Admin Exp. - 2.73 2.25 2.42 1.87 2.45 1.92 1.69 2.03 1.44 1.57 % Of Sales - 0.52% 0.46% 0.56% 0.61% 0.76% 0.81% 0.82% 0.62% 0.51% 0.59% Selling & Distn. Exp. - 9.01 8.63 7.60 6.08 6.61 5.95 5.11 8.25 5.64 6.10 % Of Sales - 1.71% 1.77% 1.76% 1.98% 2.06% 2.50% 2.48% 2.53% 1.99% 2.29% Miscellaneous Exp. - 12.77 10.62 9.51 13.02 10.21 7.49 4.03 6.80 5.37 6.10 % Of Sales - 2.42% 2.18% 2.20% 4.24% 3.18% 3.15% 1.95% 2.08% 1.89% 2.05% EBITDA 70.16 51.81 47.47 45.12 23.23 29.96 18.32 22.69 37.55 31.03 24.29 EBITDA Margin 10.96% 9.82% 9.75% 10.45% 7.57% 9.34% 7.69% 11.01% 11.51% 10.94% 9.12% Other Income 10.32 6.11 5.20 10.54 4.21 4.70 7.38 7.59 3.51 5.05 4.15 Interest 0.27 0.75 1.58 2.03 1.26 0.60 0.45 0.72 0.86 0.95 1.21 Depreciation 8.77 9.70 11.96 15.08 7.03 1.66 1.83 1.97 2.26 3.27 1.75 PBT 71.43 47.47 39.12 38.55 19.16 32.40 23.42 27.59 37.94 31.86 25.48 Tax 17.11 11.29 8.56 10.12 4.85 9.04 6.90 7.54 12.13 9.87 7.89 Tax Rate 23.95% 23.78% 21.88% 26.25% 25.31% 27.90% 29.46% 27.33% 31.97% 30.98% 30.97% PAT 54.31 36.18 30.56 28.44 14.31 23.37 16.51 20.05 25.80 21.99 17.59 PAT before Minority Interest 54.31 36.18 30.56 28.44 14.31 23.37 16.51 20.05 25.80 21.99 17.59 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.48% 6.86% 6.28% 6.58% 4.66% 7.29% 6.93% 9.73% 7.91% 7.75% 6.60% PAT Growth 53.03% 18.39% 7.45% 98.74% -38.77% 41.55% -17.66% -22.29% 17.33% 25.01% EPS 10.84 7.22 6.10 5.68 2.86 4.66 3.30 4.00 5.15 4.39 3.51

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 241.22 213.77 190.64 162.21 164.60 149.62 140.55 119.28 100.90 85.88 Share Capital 25.06 25.06 25.06 12.53 12.53 12.53 12.53 12.53 4.18 4.18 Total Reserves 216.17 188.72 165.59 149.68 152.07 137.09 128.02 106.75 96.72 81.71 Non-Current Liabilities 1.66 2.50 2.53 1.46 -0.04 -0.20 -0.49 -0.35 -0.09 0.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.58 1.54 1.51 1.17 0.87 0.95 0.73 0.78 0.58 0.26 Current Liabilities 161.34 130.91 139.47 162.71 74.80 58.63 47.42 72.48 66.81 76.88 Trade Payables 152.77 121.57 120.02 104.64 58.92 51.98 42.18 52.32 48.01 60.02 Other Current Liabilities 8.50 6.16 5.76 13.31 11.19 2.91 4.05 2.72 2.00 1.77 Short Term Borrowings 0.00 3.11 13.60 44.56 4.39 2.44 0.00 2.11 0.00 0.00 Short Term Provisions 0.07 0.06 0.10 0.20 0.31 1.30 1.19 15.33 16.80 15.09 Total Liabilities 404.22 347.18 332.64 326.38 239.36 208.05 187.48 191.41 167.62 163.26 Net Block 52.81 61.42 71.42 84.04 21.17 16.70 17.33 18.32 9.49 12.15 Gross Block 99.91 99.67 97.93 95.67 26.51 20.48 19.28 33.42 22.62 23.69 Accumulated Depreciation 47.10 38.25 26.51 11.62 5.34 3.78 1.95 15.11 13.13 11.53 Non Current Assets 96.60 88.49 94.91 103.42 87.19 53.87 49.52 40.37 24.06 21.69 Capital Work in Progress 0.00 0.10 0.00 0.00 33.85 5.92 0.26 0.19 0.33 0.18 Non Current Investment 39.68 21.21 20.37 13.70 30.03 30.70 31.13 21.03 13.27 8.03 Long Term Loans & Adv. 4.11 2.20 2.62 2.68 2.13 0.56 0.80 0.84 0.97 1.33 Other Non Current Assets 0.00 3.55 0.50 3.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 307.61 258.69 237.73 222.95 152.18 154.18 137.96 151.04 143.55 141.57 Current Investments 51.15 21.47 11.01 65.86 8.62 35.56 39.26 21.95 29.33 18.80 Inventories 72.64 79.92 81.43 61.49 42.85 31.90 29.82 23.69 16.42 19.32 Sundry Debtors 171.23 135.71 106.86 81.03 74.53 70.92 56.65 74.67 68.15 74.75 Cash & Bank 6.65 15.95 20.09 2.52 11.49 8.00 6.39 13.38 14.15 15.47 Other Current Assets 5.94 1.00 16.80 7.32 14.69 7.78 5.85 17.35 15.50 13.23 Short Term Loans & Adv. 5.27 4.63 1.53 4.73 3.43 1.06 3.90 15.34 13.88 12.11 Net Current Assets 146.28 127.78 98.26 60.25 77.38 95.55 90.55 78.55 76.75 64.69 Total Assets 404.21 347.18 332.64 326.37 239.37 208.05 187.48 191.41 167.61 163.26

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 53.90 28.86 -18.73 48.93 7.12 1.83 26.12 16.50 18.79 14.59 PBT 47.47 39.12 38.55 19.16 32.40 23.42 27.59 37.94 31.86 25.48 Adjustment 4.39 8.17 7.43 8.30 -2.12 -1.88 -4.82 -0.74 -1.41 -1.82 Changes in Working Capital 15.51 -9.29 -54.98 26.57 -13.40 -12.57 11.09 -7.96 -0.66 -2.85 Cash after chg. in Working capital 67.37 38.00 -9.00 54.03 16.89 8.96 33.86 29.23 29.79 20.81 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -13.47 -9.14 -9.73 -5.09 -9.76 -7.13 -7.73 -12.74 -11.00 -6.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -43.48 -7.82 52.20 -76.53 2.86 1.89 -20.31 -5.24 -11.86 -4.77 Net Fixed Assets -0.14 -1.84 -2.26 -35.31 -33.96 -6.86 14.07 -10.66 0.92 -0.93 Net Investments -48.15 -11.30 48.18 -40.91 27.61 4.13 -27.41 -0.38 -15.77 -7.45 Others 4.81 5.32 6.28 -0.31 9.21 4.62 -6.97 5.80 2.99 3.61 Cash from Financing Activity -12.29 -19.45 -33.12 22.17 -6.51 -5.12 -3.66 -9.00 -8.30 -7.72 Net Cash Inflow / Outflow -1.87 1.60 0.35 -5.43 3.47 -1.40 2.15 2.25 -1.37 2.10 Opening Cash & Equivalents 3.80 2.20 1.85 7.27 3.80 5.20 3.05 0.80 2.17 0.06 Closing Cash & Equivalent 1.93 3.80 2.20 1.85 7.27 3.80 5.20 3.05 0.80 2.17

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 48.14 42.66 38.04 32.37 32.85 29.86 28.05 23.80 20.13 17.14 ROA 9.63% 8.99% 8.63% 5.06% 10.44% 8.35% 10.58% 14.37% 13.29% 11.75% ROE 15.90% 15.11% 16.12% 8.75% 14.87% 11.38% 15.43% 23.44% 23.55% 21.78% ROCE 21.05% 19.33% 19.75% 10.87% 20.56% 16.31% 21.61% 34.91% 35.13% 32.94% Fixed Asset Turnover 5.31 4.97 4.55 5.20 13.71 12.23 8.23 12.19 13.02 12.95 Receivable days 105.71 90.17 77.87 89.32 82.39 95.73 110.46 76.28 86.54 82.72 Inventory Days 52.54 59.98 59.23 59.91 42.34 46.32 45.01 21.42 21.65 27.54 Payable days 125.45 117.42 125.15 102.62 71.01 80.06 97.41 64.25 79.63 83.85 Cash Conversion Cycle 32.80 32.72 11.94 46.61 53.72 61.99 58.06 33.45 28.56 26.41 Total Debt/Equity 0.00 0.01 0.07 0.27 0.03 0.02 0.00 0.02 0.00 0.00 Interest Cover 64.61 25.76 19.99 16.23 55.16 52.91 39.30 44.87 34.69 22.02

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Anuh Pharma - Quarterly Results
9th Feb 2024, 16:32 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback